Identification of Markers (Klotho-FGF23 Axis) as Determinant in the Evolution of Arterial Stiffness During the First Year of Renal Transplant
- Conditions
- Renal Transplant
- Interventions
- Biological: Biological sampleProcedure: Non invasive Arterial investigationsProcedure: Abdominal tomodensitometry
- Registration Number
- NCT02951442
- Lead Sponsor
- Hopital Foch
- Brief Summary
The primary objective is to show that the contribution of Klotho by the renal graft is an independent determinant of the evolution of the recipient's central arterial stiffness during the first year of renal transplant. The contribution of Klotho by the graft will be estimated by: its circulating concentrations assay, its urinary excretion assay, and, indirectly, by the circulating concentrations of FGF23. The recipient's central arterial stiffness will be estimated by the measure of the carotid-femoral pulse wave velocity, noninvasive reference method for measuring aortic stiffness in human.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 117
- Man or woman 18 to 70 years old
- Renal transplant
- Dead donor or alive donor
- Immunosuppression including a calcineurin inhibitor
- Written consent
- MultipleTransplant
- Morbid Obesity (Body Mass Index (BMI)> 40 kg/m2 sc)
- Cardiac Arrhythmia
- Lower limbs occlusive arterial disease
- Impossibility to understand the information form
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Renal Transplant Abdominal tomodensitometry - Renal Transplant Biological sample - Renal Transplant Non invasive Arterial investigations -
- Primary Outcome Measures
Name Time Method Carotid-femoral pulse wave velocity 12 months
- Secondary Outcome Measures
Name Time Method Sectional carotid stiffness 12 months Carotid intima-media thickness 12 months Endothelial function 12 months Arterial calcification 12 months Pulsed central veinous pressure 12 months Klotho concentration 1 day FGF23 concentration 1 day
Trial Locations
- Locations (2)
AH-HP Hôpital Necker enfants malades
🇫🇷Paris, France
Hôpital Foch
🇫🇷Suresnes, France